HL

Haleon plc (HLN)

HealthcareDrug Manufacturers - Specialty & Generic
9.23USD
+0.60%
Magic Rank
#447
Earnings Yield
4.5%
Return on Capital
> 999%
Market Cap
43.8B

Performance vs S&P 500 (5Y)

HLN.US
S&P 500

About Haleon plc

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Magic Formula Analysis

Enterprise Value51.6B
Market / Universe
us
USA

"A company with high ROC and high EY is statistically more likely to outperform the market."

Key Indicators

P/E Ratio22.23
Dividend Yield0.7%
Debt to Equity0.48
Gross Margin22.2%